Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02344186
What this trial is testing

Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Temple University 12
Not applicableLooking for participantsNCT07728669
What this trial is testing

Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)Overweight+1 more
Kazakh Academy of Nutrition 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767942
What this trial is testing

UBT251 Injection Phase Ⅲ Study (OSA-NPAP)

Who this might be right for
Obstructive Sleep Apnea, Obesity
The United Bio-Technology (Hengqin) Co., Ltd. 150
Post-approval studies (Phase 4)Not Yet RecruitingNCT07617155
What this trial is testing

GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

Who this might be right for
Hypertriglyceridemia Induced Acute PancreatitisRecurrent Acute PancreatitisPancreatitis Relapsing+1 more
Peking Union Medical College Hospital 396
Early research (Phase 1)Study completedNCT02363335
What this trial is testing

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Who this might be right for
Healthy Volunteers
National Institute on Aging (NIA) 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT06788626
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

Who this might be right for
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective Drugs+1 more
Wei Hu 390
Post-approval studies (Phase 4)Study completedNCT05218915
What this trial is testing

Basal Plus GLP1-ra on Glycemic Variability in CKD

Who this might be right for
Diabetes MellitusDiabetic Kidney Disease
Elaine Chow 95
Very early researchLooking for participantsNCT07627191
What this trial is testing

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Who this might be right for
Pancreatic CancerColorectal CancerHepatocellular Carcinoma
University of Arizona 30
Post-approval studies (Phase 4)Study completedNCT07732218
What this trial is testing

Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

Who this might be right for
Type 2 Diabetes
Rehman Medical Institute - RMI 95
Large-scale testing (Phase 3)UnknownNCT05952882
What this trial is testing

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Who this might be right for
Polycystic Ovary SyndromeObesityInfertility, Female
Mỹ Đức Hospital 188
Testing effectiveness (Phase 2)Study completedNCT05254418
What this trial is testing

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Vanderbilt University Medical Center 7
Post-approval studies (Phase 4)Not Yet RecruitingNCT07824895
What this trial is testing

Mazdutide for Weight Management and Gout in Adults With Obesity

Who this might be right for
GoutObesity (BMI>30)Hyperuricemia+1 more
Hongwei Jiang 30
Large-scale testing (Phase 3)Study completedNCT07820111
What this trial is testing

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

Who this might be right for
Obese DiabeticsObese Non Diabetic
Zagazig University 159
Large-scale testing (Phase 3)Study completedNCT01584232
What this trial is testing

Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 361
Post-approval studies (Phase 4)Looking for participantsNCT07558863
What this trial is testing

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University 60
Not applicableUnknownNCT03426956
What this trial is testing

Glucose Absorption and Gut Hormone Secretion After Gastric Bypass

Who this might be right for
Overweight
Hvidovre University Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01298830
What this trial is testing

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage (ICH)
CellMed AG, a subsidiary of BTG plc. 11
Not applicableLooking for participantsNCT07244445
What this trial is testing

Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy

Who this might be right for
Dietary ChangeObesity & OverweightFood Acceptance
Ian J. Neeland, MD 108
Not applicableStudy completedNCT01767441
What this trial is testing

Bariatric Surgeries and Glucose Homeostasis During a Mixed Meal Test

Who this might be right for
Obesity
Azienda Ospedaliera Universitaria Integrata Verona 16
Post-approval studies (Phase 4)Study completedNCT01931982
What this trial is testing

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 DiabetesMicrovascular Dysfunction
Bispebjerg Hospital 20
Next Page